Gilbert G E, Arena A A
Department of Medicine, Brockton-West Roxbury VA Medical Center, Boston, Massachusetts 02132, USA.
Biochemistry. 1998 Sep 29;37(39):13526-35. doi: 10.1021/bi972944f.
Membranes containing phosphatidyl-L-serine (PS) and phosphatidylethanolamine (PE) greatly enhance the function of the enzymatic cofactor factor VIII. The mechanisms of enhanced function involve condensation of enzyme (factor IXa), activated cofactor (factor VIIIa), and substrate (factor X) at a common location and, most dramatically, activation of the assembled enzyme-cofactor complex. We asked whether unsaturated phospholipid (PL) acyl chains are necessary to constitute factor VIII binding sites or to activate the factor VIIIa-factor IXa complex. We found that membranes composed of saturated, dimyristoyl phospholipids had 20-fold fewer factor VIII binding sites and that these sites supported less than 5% normal activity of the factor VIIIa-factor IXa complex. Thrombin-activated factor VIII bound to a similar number of membrane sites, and thrombin activation did not reduce the affinity for saturated membranes more than 2-fold so that the loss of functional activity is due to a requirement of the factor VIIIa-factor IXa complex for unsaturated acyl chains that exceeds the requirement for factor VIII binding alone. Replacement of dimyristoyl-PS, -PE, or -PC individually with the corresponding unsaturated phospholipid restored 75%, 60%, and 15%, respectively, of factor VIII binding sites but less than 10% of factor VIIIa-factor IXa activating activity. Lyso-PS did not support binding of factor VIII or function of the factor VIIIa-factor IXa complex even when PE and phosphatidylcholine contained unsaturated acyl chains. We conclude that the sn-2 acyl chain of PS and unsaturated phospholipid acyl chains are chemical requirements for constitution of fully functional factor VIII binding sites on phospholipid membranes.
含有磷脂酰-L-丝氨酸(PS)和磷脂酰乙醇胺(PE)的膜可极大地增强酶辅因子凝血因子VIII的功能。功能增强的机制包括酶(凝血因子IXa)、活化辅因子(凝血因子VIIIa)和底物(凝血因子X)在共同位置的聚集,最显著的是组装好的酶-辅因子复合物的活化。我们研究了不饱和磷脂(PL)酰基链对于构成凝血因子VIII结合位点或激活凝血因子VIIIa-凝血因子IXa复合物是否必要。我们发现由饱和的二肉豆蔻酰磷脂组成的膜上凝血因子VIII结合位点数量减少了20倍,并且这些位点支持的凝血因子VIIIa-凝血因子IXa复合物活性不到正常活性的5%。凝血酶激活的凝血因子VIII与相似数量的膜位点结合,并且凝血酶激活使对饱和膜的亲和力降低不超过2倍,因此功能活性的丧失是由于凝血因子VIIIa-凝血因子IXa复合物对不饱和酰基链的需求超过了单独凝血因子VIII结合的需求。分别用相应的不饱和磷脂替换二肉豆蔻酰-PS、-PE或-PC,可分别恢复75%、60%和15%的凝血因子VIII结合位点,但凝血因子VIIIa-凝血因子IXa激活活性恢复不到10%。溶血磷脂酰丝氨酸即使在PE和磷脂酰胆碱含有不饱和酰基链时也不支持凝血因子VIII的结合或凝血因子VIIIa-凝血因子IXa复合物的功能。我们得出结论,PS的sn-2酰基链和不饱和不饱和对磷脂膜上完全功能性凝血因子VIII结合位点的构成对不饱和磷脂酰基链有化学需求。